Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.28
-0.02-1.54%
At close: Dec 16, 4:00 PM EST
$1.24
-0.04-3.13%
After Hours: 4:26 PM EST
Comments
Loading...
BioCardia Analyst Ratings and Price Targets | NASDAQ:BCDA | Benzinga
BioCardia Inc has a consensus price target of $25 based on the ratings of 1 analysts. The high is $25 issued by HC Wainwright & Co. on September 22, 2025. The low is $25 issued by HC Wainwright & Co. on September 22, 2025. The 3 most-recent analyst ratings were released by HC Wainwright & Co. on September 22, 2025, December 18, 2024, and November 14, 2024, respectively. With an average price target of $25 between HC Wainwright & Co., there's an implied 1916.13% upside for BioCardia Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
HC Wainwright & Co.
1calculated from analyst ratings
Analyst Ratings for BioCardia
FAQ
What is the target price for BioCardia (BCDA) stock?
The latest price target for BioCardia (NASDAQ:BCDA) was reported by HC Wainwright & Co. on September 22, 2025. The analyst firm set a price target for $25.00 expecting BCDA to rise to within 12 months (a possible 1916.13% upside). 2 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for BioCardia (BCDA)?
The latest analyst rating for BioCardia (NASDAQ:BCDA) was provided by HC Wainwright & Co., and BioCardia reiterated their buy rating.
When was the last upgrade for BioCardia (BCDA)?
There is no last upgrade for BioCardia
When was the last downgrade for BioCardia (BCDA)?
There is no last downgrade for BioCardia.
When is the next analyst rating going to be posted or updated for BioCardia (BCDA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of BioCardia, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for BioCardia was filed on September 22, 2025 so you should expect the next rating to be made available sometime around September 22, 2026.
Is the Analyst Rating BioCardia (BCDA) correct?
While ratings are subjective and will change, the latest BioCardia (BCDA) rating was a reiterated with a price target of $25.00 to $25.00. The current price BioCardia (BCDA) is trading at is $1.24, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
